HomeCompareSWRAF vs MRK

SWRAF vs MRK: Dividend Comparison 2026

SWRAF yields 4.17% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SWRAF wins by $2250.30M in total portfolio value
10 years
SWRAF
SWRAF
● Live price
4.17%
Share price
$10.50
Annual div
$0.44
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2250.35M
Annual income
$2,151,183,113.88
Full SWRAF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SWRAF vs MRK

📍 SWRAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSWRAFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SWRAF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SWRAF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SWRAF
Annual income on $10K today (after 15% tax)
$354.20/yr
After 10yr DRIP, annual income (after tax)
$1,828,505,646.80/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SWRAF beats the other by $1,828,497,318.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SWRAF + MRK for your $10,000?

SWRAF: 50%MRK: 50%
100% MRK50/50100% SWRAF
Portfolio after 10yr
$1125.21M
Annual income
$1,075,596,456.01/yr
Blended yield
95.59%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SWRAF
No analyst data
Altman Z
0.9
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SWRAF buys
0
MRK buys
0
No recent congressional trades found for SWRAF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSWRAFMRK
Forward yield4.17%2.76%
Annual dividend / share$0.44$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$2250.35M$56.8K
Annual income after 10y$2,151,183,113.88$9,798.13
Total dividends collected$2243.29M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SWRAF vs MRK ($10,000, DRIP)

YearSWRAF PortfolioSWRAF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,533$833.41$11,206$366.19+$327.00SWRAF
2$14,137$1,796.65$12,650$502.35+$1.5KSWRAF
3$19,243$4,116.43$14,407$694.19+$4.8KSWRAF
4$31,064$10,473.21$16,585$967.82+$14.5KSWRAF
5$64,839$31,600.67$19,342$1,363.89+$45.5KSWRAF
6$192,667$123,289.08$22,913$1,947.19+$169.8KSWRAF
7$890,919$684,766.07$27,662$2,823.89+$863.3KSWRAF
8$6,871,903$5,918,618.88$34,159$4,173.35+$6.84MSWRAF
9$92,683,614$85,330,678.12$43,337$6,308.80+$92.64MSWRAF
10$2,250,354,581$2,151,183,113.88$56,776$9,798.13+$2250.30MSWRAF

SWRAF vs MRK: Complete Analysis 2026

SWRAFStock

Swire Pacific Limited engages in property, aviation, beverages, marine, and trading and industrial businesses in Hong Kong, Mainland China, rest of Asia, the United States, and internationally. The company's Property division develops, owns, and operates mixed-use properties. This division's property investment portfolio comprises office and retail premises, serviced apartments, other luxury residential accommodations, and commercial mixed-use developments; and trading portfolio consists of residential properties. It also owns and manages two hotels in Hong Kong and four hotels in Mainland China, as well as owns interests in the Mandarin Oriental hotel in the United States. The company's Aviation division provides flight catering and ramp, passenger and cargo services, and aircraft maintenance and modification services. As of December 31, 2021, it had a fleet of 234 aircraft. Its Beverages division owns rights to manufacture, market, and distribute refreshing soft drinks to consumers. The company's Trading & Industrial division retails and distributes footwear, apparel, and accessories through its 164 retail outlets; sells passenger cars, commercial vehicles, motorcycles, and scooters; operates a chain of 538 bakery stores; packages and sells sugar products under the Taikoo Sugar brand; and offers waste management services. The company was founded in 1816 and is based in Central, Hong Kong.

Full SWRAF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SWRAF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SWRAF vs SCHDSWRAF vs JEPISWRAF vs OSWRAF vs KOSWRAF vs MAINSWRAF vs JNJSWRAF vs ABBVSWRAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.